Partnerships

Flow-Through Partnerships Economic Impact Payouts Valuation Loan Guarantees

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

The collaboration aims to develop four GPCR-targeted small-molecule treatments, diversifying Novo Nordisk’s portfolio amid rising competition from Eli Lilly.

11 ARTICLES

last yr.

New York Times Sues OpenAI and Microsoft Over Copyright Infringement